Law school prepares attorneys to condense complex sets of facts into concise, persuasive arguments that achieve client objectives. These writing skills are even more critical when drafting responses and applications to FDA that are predicated on complex scientific and technical arguments.
Because regulations are legally binding requirements based upon statutory laws and judicial opinions, it is essential that professionals in the pharmaceutical and medical device companies clearly understand and effectively employ legal writing techniques to frame persuasive argument when negotiating with FDA. The success or failure of many new drugs, biologic or medical device projects hinges on presenting essential information in a persuasive manner. Do you use these legal drafting skills when preparing quality and regulatory documents?
In this webinar, you will learn the legal writing skills and practical techniques that will enhance your chances for success even if some of your test results or other supporting information are somewhat lacking. Remember, good regulatory writing will meet FDA branch-level requirements but the best and most effective submissions can withstand scrutiny at the FDA Division level.
Why should you Attend:
Most regulatory, quality and R&D professionals rise within an organization due to their scientific and technical understanding of the products in their company’s pipeline. However, those professionals who can prepare written and oral arguments that effectively persuasive regulatory agencies to agree with their positions are the one who achieve the highest levels of success within the organization. Lawyers know these writing techniques – do you?
Areas Covered in the Session:
Who Will Benefit:
Robert Michalik J.D, RAC, is a Massachusetts regulatory attorney and founder of RegulatoryPro.com, a consulting firm providing general and specialized services to the biopharmaceutical and medical device industries. Mr. Michalik has over 25 years’ experience working in the biopharmaceutical and medical device industries. Starting with a bachelor’s degree in science (biochemistry), Bob has held a wide variety of technical, quality and regulatory positions that literally span the scope of new product development and commercialization activities. Mr. Michalik is former faculty member with Northeastern University (Boston, MA) Master’s Program in FDA Regulatory Affairs.